| Date Filed | Type | Description |
| 01/30/2023 |
SC 13D/A
| venBio Global Strategic Fund III, L.P. reports a 4.8% stake in Ventyx Biosciences, Inc. |
| 12/15/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 09/26/2022 |
SC 13D/A
| venBio Global Strategic Fund III, L.P. reports a 6.9% stake in Pharvaris N.V. |
| 09/26/2022 |
SC 13D/A
| venBio Global Strategic Fund III, L.P. reports a 8% stake in Elevation Oncology, Inc. |
| 09/26/2022 |
SC 13G/A
| venBio Global Strategic Fund III, L.P. reports a 4.9% stake in CinCor Pharma, Inc. |
| 09/14/2022 |
SC 13D/A
| venBio Global Strategic Fund III, L.P. reports a 10% stake in Ventyx Biosciences, Inc. |
| 06/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/27/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 01/11/2022 |
SC 13G
| venBio Global Strategic Fund III, L.P. reports a 5.6% stake in CinCor Pharma, Inc. |
| 11/04/2021 |
SC 13D
| venBio Global Strategic Fund III, L.P. reports a 10% stake in Ventyx Biosciences, Inc. |
| 10/25/2021 |
4
| venBio Global Strategic Fund III, L.P. (10% Owner) has filed a Form 4 on Ventyx Biosciences, Inc.|
Txns:
| Converted 3,684,769 shares
@ $0
Bought 312,500 shares
@ $16, valued at
$5M
Converted 3,289,742 preferred shares
@ $0
Converted 395,027 preferred shares
@ $0 |
|
| 10/20/2021 |
3
| venBio Global Strategic Fund III, L.P. (10% Owner) has filed a Form 3 on Ventyx Biosciences, Inc. |
| 07/09/2021 |
SC 13D
| venBio Global Strategic Fund III, L.P. reports a 11.4% stake in Elevation Oncology, Inc. |
| 07/01/2021 |
4
| venBio Global Strategic Fund III, L.P. (10% Owner) has filed a Form 4 on Elevation Oncology, Inc.|
Txns:
| Converted 1,983,167 shares
@ $0
Bought 625,000 shares
@ $16, valued at
$10M
Converted 8,380,034 preferred shares
@ $0 |
|
| 06/24/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 02/19/2021 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
| 03/26/2020 |
D/A
| Form D/A - Notice of Exempt Offering of Securities: [Amend] |
| 03/26/2019 |
D/A
| Form D/A - Notice of Exempt Offering of Securities: [Amend] |
| 06/13/2018 |
D
| Form D - Notice of Exempt Offering of Securities: |